{
  "attributes": {
    "type": "BDL_Deal_Risk_Assessment__c"
  },
  "records": [
    {
      "attributes": {
        "type": "BDL_Deal_Risk_Assessment__c",
        "referenceId": "DealRiskAssessmentRef1"
      },
      "BDL_Opportunity__c": "OpportunityRef1",
      "BDL_Assessment_Type__c": "Supply Point Evaluation",
      "BDL_Risk_Description__c": "Still waiting for Site Inspection results from 2022",
      "BDL_Mitigation_Plan__c": "Closely collaborating with Alliances and making sure documents come in as fast as possible.",
      "BDL_Risk__c": "Medium",
      "BDL_Role__c": "Regulatory",
      "BDL_Summary__c": "In Progress"
    },
    {
      "attributes": {
        "type": "BDL_Deal_Risk_Assessment__c",
        "referenceId": "DealRiskAssessmentRef2"
      },
      "BDL_Opportunity__c": "OpportunityRef1",
      "BDL_Assessment_Type__c": "Clinical",
      "BDL_Risk_Description__c": "To be assessed on how this fits into our portfolio strategy.",
      "BDL_Mitigation_Plan__c": "Needs to be raised with deal team and prognoses to be calculated.",
      "BDL_Risk__c": "Medium",
      "BDL_Role__c": "Therapeutics Area VP",
      "BDL_Summary__c": null
    }
  ]
}